Orbimed Advisors increased stake in X4 Pharmaceuticals, Inc.

This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXMPECBE0OL_M.jpg

Orbimed Advisors’s holding in X4 Pharmaceuticals, Inc. increased to about 1.8 million shares with the purchase.

Orbimed Advisors first bought X4 Pharmaceuticals, Inc. stock in the first quarter of 2019.

Other investors who also added to their X4 Pharmaceuticals, Inc. shares include Citigroup (NYSE:C) and Squarepoint Ops.

Add Comment